Cargando…

Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients

BACKGROUND: There is wide variation in clinical presentation and outcome of lupus nephritis (LN) among different ethnic groups. Few data for LN exist on North Africans, especially those from Morocco. The aim of our study was to review retrospectively the features and outcome of LN in Moroccan patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddiya, Intissar, Hamzaoui, Hakim, Tachfouti, Nabil, Hamany, Zitouna Al, Radoui, Aicha, Zbiti, Najoua, Amar, Yamama, Rhou, Hakima, Benamar, Loubna, Ouzeddoun, Naima, Bayahia, Rabea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839844/
https://www.ncbi.nlm.nih.gov/pubmed/24294005
http://dx.doi.org/10.2147/IJNRD.S34299
_version_ 1782478443361861632
author Haddiya, Intissar
Hamzaoui, Hakim
Tachfouti, Nabil
Hamany, Zitouna Al
Radoui, Aicha
Zbiti, Najoua
Amar, Yamama
Rhou, Hakima
Benamar, Loubna
Ouzeddoun, Naima
Bayahia, Rabea
author_facet Haddiya, Intissar
Hamzaoui, Hakim
Tachfouti, Nabil
Hamany, Zitouna Al
Radoui, Aicha
Zbiti, Najoua
Amar, Yamama
Rhou, Hakima
Benamar, Loubna
Ouzeddoun, Naima
Bayahia, Rabea
author_sort Haddiya, Intissar
collection PubMed
description BACKGROUND: There is wide variation in clinical presentation and outcome of lupus nephritis (LN) among different ethnic groups. Few data for LN exist on North Africans, especially those from Morocco. The aim of our study was to review retrospectively the features and outcome of LN in Moroccan patients. PATIENTS AND METHODS: We performed a single-center retrospective study. A total of 114 patients with LN were included. All patients met American Rheumatism Association criteria. LN was classified according to the International Society of Nephrology/Renal Pathology Society classification. We adopted previously defined outcome criteria for LN. RESULTS: There were 101 females and 13 males, with a mean age of 29.9 years. At first presentation, we noted hypertension in 33%, hematuria in 76%, nephrotic syndrome in 53%, and renal failure in 60% of cases. Renal biopsy revealed predominant proliferative classes in more than 80% of patients. Patients received different regimens mainly based on intravenous cyclophosphamide. After a mean follow-up of 22 months, remission occurred in 45.5%, relapses in 82%, end-stage renal failure in 21%, and death in 16% of cases. Infection and neurological and cardiovascular diseases were the most frequent causes of death. CONCLUSION: LN seems to be severe in our study, with a predominance of proliferative forms, severe renal manifestations, and poor renal and overall survival.
format Online
Article
Text
id pubmed-3839844
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38398442013-11-29 Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients Haddiya, Intissar Hamzaoui, Hakim Tachfouti, Nabil Hamany, Zitouna Al Radoui, Aicha Zbiti, Najoua Amar, Yamama Rhou, Hakima Benamar, Loubna Ouzeddoun, Naima Bayahia, Rabea Int J Nephrol Renovasc Dis Case Series BACKGROUND: There is wide variation in clinical presentation and outcome of lupus nephritis (LN) among different ethnic groups. Few data for LN exist on North Africans, especially those from Morocco. The aim of our study was to review retrospectively the features and outcome of LN in Moroccan patients. PATIENTS AND METHODS: We performed a single-center retrospective study. A total of 114 patients with LN were included. All patients met American Rheumatism Association criteria. LN was classified according to the International Society of Nephrology/Renal Pathology Society classification. We adopted previously defined outcome criteria for LN. RESULTS: There were 101 females and 13 males, with a mean age of 29.9 years. At first presentation, we noted hypertension in 33%, hematuria in 76%, nephrotic syndrome in 53%, and renal failure in 60% of cases. Renal biopsy revealed predominant proliferative classes in more than 80% of patients. Patients received different regimens mainly based on intravenous cyclophosphamide. After a mean follow-up of 22 months, remission occurred in 45.5%, relapses in 82%, end-stage renal failure in 21%, and death in 16% of cases. Infection and neurological and cardiovascular diseases were the most frequent causes of death. CONCLUSION: LN seems to be severe in our study, with a predominance of proliferative forms, severe renal manifestations, and poor renal and overall survival. Dove Medical Press 2013-11-22 /pmc/articles/PMC3839844/ /pubmed/24294005 http://dx.doi.org/10.2147/IJNRD.S34299 Text en © 2013 Haddiya et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Case Series
Haddiya, Intissar
Hamzaoui, Hakim
Tachfouti, Nabil
Hamany, Zitouna Al
Radoui, Aicha
Zbiti, Najoua
Amar, Yamama
Rhou, Hakima
Benamar, Loubna
Ouzeddoun, Naima
Bayahia, Rabea
Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients
title Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients
title_full Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients
title_fullStr Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients
title_full_unstemmed Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients
title_short Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients
title_sort features and outcomes of lupus nephritis in morocco: analysis of 114 patients
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839844/
https://www.ncbi.nlm.nih.gov/pubmed/24294005
http://dx.doi.org/10.2147/IJNRD.S34299
work_keys_str_mv AT haddiyaintissar featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT hamzaouihakim featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT tachfoutinabil featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT hamanyzitounaal featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT radouiaicha featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT zbitinajoua featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT amaryamama featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT rhouhakima featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT benamarloubna featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT ouzeddounnaima featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients
AT bayahiarabea featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients